ARCHIVES

ODAC Recommendation for Pertuzumab Signals FDA’s Resolve In Granting Accelerated Approvals

This article is from The Cancer Letter archive.

Vol. 39 No. 35 | September 20, 2013

Download PDF Visit The Full Archive

Related Articles

Organ Systems Support Contract To Cost More than OSCC Grant

September 30, 1988

In Brief: Mayo Director Kovach Moves To City Of Hope; Seattle Institutions Win Gene Therapy

May 20, 1994

NCI advisors approve recompetition of $62 million phase II contracts program.

November 19, 2004

Health Organizations: ACS Statement Supports funding of Research On Human Stem cells

December 17, 1999

NCAB Congress to Keep Cigarette Tax At 16 Cents

May 24, 1985

Consortium Centers Pose Problems To Some, But claim They “Coincide With Congress’ Intent”

December 9, 1977